LTIP599A - Novel, biologically active eburnamenine derivatives and a process for preparing the same - Google Patents

Novel, biologically active eburnamenine derivatives and a process for preparing the same

Info

Publication number
LTIP599A
LTIP599A LTIP599A LTIP599A LTIP599A LT IP599 A LTIP599 A LT IP599A LT IP599 A LTIP599 A LT IP599A LT IP599 A LTIP599 A LT IP599A LT IP599 A LTIP599 A LT IP599A
Authority
LT
Lithuania
Prior art keywords
preparing
novel
same
biologically active
eburnamenine derivatives
Prior art date
Application number
LTIP599A
Inventor
Zoltan Tuba
Sandor Maho
Aniko Gere
Pal Vittay
Bela Kiss
Eva Palosi
Lazlo Szporny
Csaba Szantay
Ferenc Soti
Zsuzsa Balogh
Maria Incze
Gabor Balogh
Maria Gazdag
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of LTIP599A publication Critical patent/LTIP599A/en
Publication of LT3118B publication Critical patent/LT3118B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D461/00—Heterocyclic compounds containing indolo [3,2,1-d,e] pyrido [3,2,1,j] [1,5]-naphthyridine ring systems, e.g. vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
LTIP599A 1992-06-09 1993-06-02 Novel, biologically active eburnamenine derivatives and a process for preparing the same LT3118B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9201911A HU209678B (en) 1992-06-09 1992-06-09 Process for producing biologically active eburnamenin-14-carbonyl-amino derivatives and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
LTIP599A true LTIP599A (en) 1994-07-15
LT3118B LT3118B (en) 1994-12-27

Family

ID=10982021

Family Applications (1)

Application Number Title Priority Date Filing Date
LTIP599A LT3118B (en) 1992-06-09 1993-06-02 Novel, biologically active eburnamenine derivatives and a process for preparing the same

Country Status (18)

Country Link
US (1) US5510345A (en)
EP (1) EP0644885A1 (en)
JP (1) JPH07507793A (en)
KR (1) KR950701924A (en)
AU (1) AU4352493A (en)
CA (1) CA2136547A1 (en)
CZ (1) CZ307994A3 (en)
EE (1) EE9400070A (en)
FI (1) FI945780A7 (en)
GR (1) GR1001597B (en)
HR (1) HRP930957A2 (en)
HU (1) HU209678B (en)
IL (1) IL105942A0 (en)
LT (1) LT3118B (en)
NZ (1) NZ253308A (en)
SI (1) SI9300309A (en)
WO (1) WO1993025550A1 (en)
ZA (1) ZA934037B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2316458A1 (en) 2004-09-20 2011-05-04 Xenon Pharmaceuticals Inc. Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase
US7767677B2 (en) 2004-09-20 2010-08-03 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
US7951805B2 (en) 2004-09-20 2011-05-31 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase
EP1804799B1 (en) 2004-09-20 2013-08-21 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
EP2289510A1 (en) 2004-09-20 2011-03-02 Xenon Pharmaceuticals Inc. Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes
EP1799667B1 (en) 2004-09-20 2013-03-20 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as therapeutic agents
CA2580856A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
EP1805142A4 (en) * 2004-09-23 2009-06-10 Reddy Us Therapeutics Inc Novel pyridine compounds, process for their preparation and compositions containing them
EP2029138A1 (en) 2005-06-03 2009-03-04 Xenon Pharmaceuticals Inc. Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
WO2009120094A2 (en) * 2008-03-27 2009-10-01 Auckland Uniservices Limited Substituted pyrimidines and triazines and their use in cancer therapy
CN101928286A (en) * 2009-06-18 2010-12-29 谢开智 Pervone derivative and preparation method thereof
MX364895B (en) 2013-03-13 2019-05-10 Forma Therapeutics Inc Novel compounds and compositions for inhibition of fasn.
WO2017210545A1 (en) 2016-06-02 2017-12-07 Cadent Therapeutics, Inc. Potassium channel modulators
EP3571193B1 (en) 2017-01-23 2021-12-01 Cadent Therapeutics, Inc. Potassium channel modulators
MX2021004647A (en) 2018-10-22 2021-08-16 Novartis Ag CRYSTALLINE FORMS OF POTASSIUM CHANNELS MODULATORS.
CN113382633A (en) 2018-10-29 2021-09-10 福马治疗股份有限公司 Solid forms of (4- (2-fluoro-4- (1-methyl-1H-benzo [ d ] imidazol-5-yl) benzoyl) piperazin-1-yl) (1-hydroxycyclopropyl) methanone

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2176516B1 (en) * 1972-03-22 1975-03-14 Synthelabo
HU171663B (en) * 1975-09-01 1978-02-28 Richter Gedeon Vegyeszet Process for producing new 14-bracket-substituted-methyl-bracket closed-vincane derivatives
US4547505A (en) * 1983-03-25 1985-10-15 Degussa Aktiengesellschaft N-Phenyl-N-'-cycloalkylalkanoylpiperazine useful as analgetics and process for its production
WO1987001706A2 (en) 1985-09-12 1987-03-26 The Upjohn Company C20 through c26 amino steroids
US5099019A (en) * 1985-09-12 1992-03-24 Upjohn Company Amines useful in producing pharmaceutically active CNS compounds
AU7580187A (en) 1986-06-23 1988-01-12 Upjohn Company, The Androstane-type and cortical aminoesters
AU1704588A (en) 1987-04-03 1988-11-02 Upjohn Company, The Amino-9,10-secosteroids
CA1338012C (en) 1987-04-27 1996-01-30 John Michael Mccall Pharmaceutically active amines
FR2644788B1 (en) 1989-03-22 1995-02-03 Roussel Uclaf NOVEL 3-CETO STEROIDS COMPRISING AN AMINO-SUBSTITUTED 17-CHAIN, THEIR PREPARATION METHOD AND THE INTERMEDIATES THEREOF, THEIR APPLICATION AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2644789B1 (en) 1989-03-22 1995-02-03 Roussel Uclaf NOVEL 19-NOR, 3-CETO STEROIDS COMPRISING AN AMINOSUBSTITUTED 17-CHAIN, THEIR PREPARATION METHOD AND THE INTERMEDIATES THEREOF, THEIR APPLICATION AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2644787B1 (en) 1989-03-22 1995-02-03 Roussel Uclaf NOVEL AMINOSUBSTITUTED STEROIDS 21, THEIR PREPARATION PROCESS AND THE INTERMEDIATES THEREOF, THEIR APPLICATION AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
WO1991011453A2 (en) 1990-01-26 1991-08-08 The Upjohn Company 5-oxygenated-2,4,6-triaminopyrimidines

Also Published As

Publication number Publication date
CZ307994A3 (en) 1995-07-12
HRP930957A2 (en) 1995-02-28
KR950701924A (en) 1995-05-17
AU4352493A (en) 1994-01-04
ZA934037B (en) 1994-01-06
FI945780A0 (en) 1994-12-08
LT3118B (en) 1994-12-27
EP0644885A1 (en) 1995-03-29
WO1993025550A1 (en) 1993-12-23
IL105942A0 (en) 1993-10-20
JPH07507793A (en) 1995-08-31
CA2136547A1 (en) 1993-12-23
HU209678B (en) 1994-10-28
HUT64540A (en) 1994-01-28
NZ253308A (en) 1995-11-27
EE9400070A (en) 1995-12-15
FI945780A7 (en) 1994-12-08
HU9201911D0 (en) 1992-09-28
GR1001597B (en) 1994-06-30
SI9300309A (en) 1993-12-31
US5510345A (en) 1996-04-23

Similar Documents

Publication Publication Date Title
EP0629608A3 (en) N-acyl-N,N'N'-ethylenediaminetriacetic acid derivatives and process for preparing same.
ZA915683B (en) Substituted azoles,a process for their preparation and their use
HUT72166A (en) Herbicides containing 4-benzoylisoxazole derivatives and process for producing the active ingredient
NZ238552A (en) Benzodiazepin-2-amine derivatives; preparatory processes, use, and medicaments
AU3788189A (en) 3, 9-diphosphaspiroundecanes and process for making3, 9-diphosphaspiroundecanes
HUP9903733A3 (en) New phenylamidine derivatives, a process for preparing the same and their use as medicaments
ZA934037B (en) Novel biologically active eburnamenine derivatives, pharmaceutical compositions containing them and process for preparing same.
EP0474129A3 (en) 1,4-dihydropyridine derivatives and process for preparing the same
HRP931016A2 (en) Thienothiazin derivatives, process for the preparation and application thereof
AU1077992A (en) Process for preparing 1,3-dioxols
EG19339A (en) Imidazolidine derivatives, process for producing the same and pesticides containing the same
EP0621866A4 (en) Process for preparing 3-acylestratrienes and acylbenzenes.
GB2218987B (en) Imidazole derivatives and a process for the preparation thereof
EP0636611A3 (en) Optically active 1,4-dihydropyridine derivatives and process for preparing the same.
HUT71953A (en) A process for the preparation of 2,3,5,6-tetrachloro-pyridine
PH31154A (en) Process for preparing 1-alkylryl-2-alkyl-5-formyl-imidazole.
EP0549263A3 (en) A process for the preparation of n-alkyl-3,4-dialkyloxyanilines and derivatives thereof
ZA929736B (en) Benzofuranylimidazole derivatives, a process for the preparation and therapeutical compositions containing the same.
IL104477A0 (en) Process for preparing 4,6-dialkoxy-pyrimidines
HUP9701922A3 (en) Substituted 7,12-dioxabenz[a]antracene derivatives, process for preparing the same and pharmaceuticals containing them
ZA913719B (en) Nitrogen containing compounds,a process for their preparation and use of the compounds
EP0542303A3 (en) Process for preparing a biologically active bloodserum
GR1002048B (en) Phenilacetic acid derivatives, process for the preparation thereof and corresponding use.
EG20262A (en) A process for preparing 1,2,3,9- tetrahydro -9- methyl -3-( 2- metyl -1H-imidazol -1- YL) methyl) -4H- carbazol -4- one
IL101103A0 (en) Physiologically active kanglemycin c,process for preparing the same and use thereof

Legal Events

Date Code Title Description
MM9A Lapsed patents

Effective date: 19960602